Kate Hardey

Kate Hardey

Katten Muchin Rosenman LLP

Contact
View Bio
RSS

Latest Posts › Export Controls

Share:

FDA Scrutinizes Clinical Trials Exporting U.S. Genetic Material

On June 18, 2025, the U.S. Food and Drug Administration (“FDA”) announced an immediate review of new clinical trials that export American citizens’ biological materials to countries of concern, such as China, for genetic...more

7/1/2025  /  China , Clinical Trials , Data Privacy , Export Controls , Food and Drug Administration (FDA) , Genetic Materials , National Security , Personal Data , Regulatory Requirements , Sensitive Personal Information
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide